[1] SESHADRI S,BEISER A,PIKULA A,et al.Parental occurrence of stroke and risk of stroke intheir children:the Framingham study[J]. Circulation,2010,121(11):1304-1312.[2] GRETARSDOTTIR S,THORLEIFSSON G,MANOLESCU A,et al. Risk variants for atrialfibrillation on chromosome 4q25 associate withischemic stroke[J]. Ann Neurol,2008,64(4):402-409.[3] 孙一忞,吴志英. CADASIL患者的临床、影像和Notch3基因突变特点及我国研究现状[J]. 中国卒中杂志,2012,7(2):136-140.[4] FUKUTAKE T. Cerebral autosomal recessivearteriopathy with subcortical infarcts andleukoencephalopathy(CARASIL):from discoveryto gene identification[J]. J Stroke Cerebrovasc Dis,2011,20(2):85-93.[5] LAWRENCE C,WEBB J. Sickle Cell Disease andStroke:Diagnosis and Management[J]. Curr NeurolNeurosci Rep,2016,16(3):27.[6] TALAHMA M,STRBIAN D,SUNDARARAJANS. Sickle cell disease and stroke[J/OL]. Stroke,2014,45(6):e98-100. http://doi.org/10.1161/STROKEAHA.114.005144.[7] RUSSELL M O,GOLDBERG H I,HODSON A,etal. Effect of transfusion therapy on arteriographicabnormalities and on recurrence of stroke in sicklecell disease[J]. Blood,1984,63(1):162-169.[8] SCHATZ J,BROWN R T,PASCUAL J M,et al.Poor school and cognitive functioning with silentcerebral infarcts and sickle cell disease[J]. Neurology,2001,56(8):1109-1111.[9] YUASA T,TAKENAKA T,HIGUCHI K,et al.Fabry disease[J]. J Echocardiogr,2017,15(4):151-157.[10] MEHTA A,GINSBERG L,FOS INVESTIGATORS.Natural history of the cerebrovascular complicationsof Fabry disease[J]. Acta Paediatr Suppl,2005,94(447):24-27.[11] LIDOVE O,WEST ML,PINTOS-MORELL G,etal. Effects of enzyme replacement therapy in Fabrydisease--a comprehensive review of the medicalliterature[J]. Genet Med,2010,12(11):668-679.[12] KUO D S,LABELLE-DUMAIS C,GOULD DB. COL4A1 and COL4A2 mutations and disease:insights into pathogenic mechanisms and potentialtherapeutic targets[J/OL]. Hum Mol Genet,2012,21(R1):R97-110. https://doi.org/10.1093/hmg/dds346.[13] GOULD D B,PHALAN F C,VAN MIL S E,etal. Role of COL4A1 in small-vessel disease andhemorrhagic stroke[J]. N Engl J Med,2006,354(14):1489-1496.[14] LANFRANCONI S,MARKUS H S. COL4A1mutations as a monogenic cause of cerebral smallvessel disease:a systematic review[J/OL]. Stroke,2010,41(8):e513-518. http://doi.org/10.1161/STROKEAHA.110.581918.[15] ALAMOWITCH S,PLAISIER E,FAVROLE P,et al. Cerebrovascular disease related to COL4A1mutations in HANAC syndrome[J]. Neurology,2009,73(22):1873-1882.[16] MCCULLY K S. Vascular pathology ofhomocysteinemia:implications for the pathogenesisof arteriosclerosis[J]. Am J Pathol,1969,56(1):111-128.[17] GUNGOR L,POLAT M,OZBERK M B,et al.Which Ischemic Stroke Subtype Is Associated withHyperhomocysteinemia?[J]. J Stroke CerebrovascDis,2018,27(7):1921-1929.[18] WU G H,KONG F Z,DONG X F,et al. Associationbetween hyperhomocysteinemia and stroke withatherosclerosis and small artery occlusion dependson homocysteine metabolism-related vitamin levelsin Chinese patients with normal renal function[J].Metab Brain Dis,2017,32(3):859-865.[19] HOLLIDAY E G,TRAYLOR M,MALIK R,etal. Genetic overlap between diagnostic subtypes ofischemic stroke[J]. Stroke,2015,46(3):615-619.[20] TRAYLOR M,FARRALL M,HOLLIDAY E G,etal. Genetic risk factors for ischaemic stroke and itssubtypes(the METASTROKE collaboration):ameta-analysis of genome-wide association study[J].Lancet Neurol,2012,11(11):951-962.[21] WILLIAMS F M,CARTER A M,HYSI P G,etal. Ischemic stroke is associated with the ABO locus:the EuroCLOT study[J]. Ann Neurol,2013,73(1):16-31.[22] SCHILLING S,DESTEFANO A L,SACHDEVP S,et al. APOE genotype and MRI markers ofcerebrovascular disease:systematic review andmeta-analysis[J]. Neurology,2013,81(3):292-300.[23] ILINCA A,SAMUELSSON S,PICCINELLIP,et al. A stroke gene panel for whole-exomesequencing[J]. Eur J Hum Genet,2018,27(2):317-324.